Kamyar Kalantar-Zadeh M.D. to Hemoglobins
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Hemoglobins.
Connection Strength
4.150
-
Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes. Am J Nephrol. 2018; 47(5):333-342.
Score: 0.555
-
Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis. Am J Nephrol. 2017; 46(5):397-407.
Score: 0.535
-
Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin. Am J Hematol. 2012 Aug; 87(8):833-6.
Score: 0.367
-
Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011 Aug; 6(8):1973-81.
Score: 0.346
-
Darbepoetin alfa and chronic kidney disease. N Engl J Med. 2010 Feb 18; 362(7):654; author reply 655.
Score: 0.313
-
Hemoglobin variability in anemia of chronic kidney disease. J Am Soc Nephrol. 2009 Mar; 20(3):479-87.
Score: 0.292
-
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis. 2008 Oct; 52(4):727-36.
Score: 0.283
-
Target haemoglobin concentrations in chronic kidney disease. Lancet. 2007 May 05; 369(9572):1515-1516.
Score: 0.258
-
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol. 2006 Apr; 17(4):1181-91.
Score: 0.239
-
Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort. Nephrol Dial Transplant. 2017 02 01; 32(2):370-377.
Score: 0.127
-
Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1814-21.
Score: 0.115
-
Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease. Nephrol Dial Transplant. 2016 04; 31(4):636-45.
Score: 0.114
-
Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients. Clin Transplant. 2012 Sep-Oct; 26(5):782-91.
Score: 0.090
-
Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients. Am J Nephrol. 2012; 35(2):198-208.
Score: 0.090
-
High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. Am J Clin Nutr. 2011 Sep; 94(3):945-54.
Score: 0.087
-
Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis. 2009 May; 53(5):823-34.
Score: 0.074
-
Epoetin dosing and dialysis facility ownership. JAMA. 2007 Aug 22; 298(8):862; author reply 862-3.
Score: 0.066
-
Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients? Nephrol News Issues. 2007 Jan; 21(1):34-8.
Score: 0.063
-
Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int. 2006 Feb; 69(3):560-4.
Score: 0.059
-
New Options for Iron Supplementation in Maintenance Hemodialysis Patients. Am J Kidney Dis. 2016 Mar; 67(3):367-75.
Score: 0.029
-
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis. 1995 Aug; 26(2):292-9.
Score: 0.029
-
Serum erythropoietin level and mortality in kidney transplant recipients. Clin J Am Soc Nephrol. 2011 Dec; 6(12):2879-86.
Score: 0.022